Preparing for Patient-Centric Drug Development Regulations

17:05 - 17:50

  • What do the recent FDA Guidelines on Patient-Focused Drug Development (PFDD) mean to us?
  • Why do we need more patient focussed thinking and design of drug products, medical devices and combination products?
  • How will become more patient focussed shake up the industry and make us more competitive

Diane Harper, Director Regulatory Affairs-CMC, Merck

Galen Shi, Senior Engineering Advisor, Eli Lilly

Graham Jones, Director of Innovation, Novartis

Paul Upham, Head, Smart Devices, Genentech